Publication | Closed Access
Interaction of sulbactam, clavulanic acid and tazobactam with penicillin-binding proteins of imipenem-resistant and -susceptible<i>acinetobacter baumannii</i>
70
Citations
13
References
1995
Year
Available AntibioticsMicrobial PathogensPenicillin-binding ProteinsAntimicrobial ChemotherapyAntibiotic ResistanceBacterial PathogensDrug ResistanceAcinetobacter BaumanniiAntibacterial MechanismsAntimicrobial ResistanceHealth SciencesAntimicrobial Drug DiscoveryClavulanic AcidAntibacterial AgentAntimicrobial PharmacokineticsAntimicrobial CompoundBacterial ResistancePharmacologyClinical MicrobiologyAntimicrobial SusceptibilityAntibioticsMicrobiologyMedicinePenicillin Binding Proteins
We have encountered clinical isolates of Acinetobacter baumannii which are resistant to all available antibiotics used in hospitals except for polymyxin B and the beta-lactamase inhibitor, sulbactam. To investigate the mechanisms of this unique activity, affinities of sulbactam and other beta-lactamase inhibitors for penicillin binding proteins were compared using imipenem-resistant and imipenem-sensitive isolates. The results of competition binding experiments indicate that all three beta-lactamase inhibitors bound to imipenem-susceptible Acinetobacter. Binding of sulbactam was greater than that of tazobactam and not detected with clavulanic acid to penicillin binding proteins of the imipenem-resistant strain of Acinetobacter.
| Year | Citations | |
|---|---|---|
Page 1
Page 1